The emergence of antibiotic-resistant pathogens has rekindled interest toward the discovery of new antibiotics. Semi-synthetic or biosynthetic approach using microbe as a biocatalyst can be an efficient tool for the targeted modification of existing antibiotic chemical scaffolds to create the next generation of antibiotics as well as previously uncharacterized therapeutic agents. 1 The macrolide antibiotics are a group of polyketides whose activity is derived from the presence of a large macrocyclic lactone ring. They are a structurally diverse class of natural products that show a wide variety of bioactive properties, including anticancer, antifungal, immuno-suppressive and anti-aging activity. 2 Oligomycin A, which was first isolated from a culture of soil bacterium Streptomyces diastatochromogenes in 1954, is a major component of oligomycins as a series of 26-membered macrocyclic lactones (Figure 1). 3 This antibiotic has also been reported to possess some potential antitumor activity. 4 Tilmicosin, a semi-synthetic tylosin that occurs as a 16-membered macrolide in the fermentation of S. fradiae, has use as a veterinary antibiotic (Figure 1). 5 We recently reported the unique and regio-specific hydrogenation activity toward unsaturated 12-(methymycin) and 14-membered (pikromycin) macrolides by S. venezuelae, and its application to the generation of unnatural 16-membered macrolides. 6 This bacterial reduction system could recognize the specific structural elements around the target double bond, that is, a carbonyl functional group on the neighboring carbon and a methyl group onto another adjoining carbon in the polyketide backbone (depicted as faded rectangles in Figure 1).In this study, an attempt was made to expand the applicability of the unique bio-hydrogenation activity of S. venezuelae toward other unsaturated macrolide antibiotics (natural oligomycin A and semisynthetic tilmicosin) that possess the above mentioned identical catalytic scaffold, and the structure and antibiotic potential of two previously uncharacterized macrolides, 2,3-dihydro-oligomycin A (1) and 10,11-dihydro-tilmicosin (2), isolated from a S. venezuelae culture supplemented with oligomycin A and tilmicosin, respectively, were evaluated.A recombinant strain of S. venezuelae YJ028, 6 which had both the pikromycin polyketide synthase-encoding gene and desosamine biosynthetic genes deleted, was provided with oligomycin A or tilmicosin. The organism was cultivated in SCM media (1.5% soluble starch, 2.0% soytone, 0.01% CaCl 2 , 0.15% yeast extract, and 1.0% MOPS) in baffled Erlenmeyer flasks. After 2 days growth at 30 1C, the cultures were supplemented with either macrolides oligomycin A (Sigma, St Louis, MO, USA) and tilmicosin (Sigma) at a final concentration of 5 mg ml À1 , and then incubated for additional 3 days. The whole cultures were extracted and partitioned using EtOAc, and then the organic extracts were concentrated under vacuum. The dried residues were dissolved in 200 ml of MeOH and a portion of the solvent was subjected to HPL...